Combination Product: Laser, exercise, and methotrexate ( DrugBank: Methotrexate )
1 disease
| ID | Disease name (Link within this page) | Number of trials |
|---|---|---|
| 46 | Malignant rheumatoid arthritis | 1 |
46. Malignant rheumatoid arthritis
Clinical trials : 4,356 / Drugs : 2,567 - (DrugBank : 415) / Drug target genes : 192 - Drug target pathways : 228
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT04758689 (ClinicalTrials.gov) | November 20, 2020 | 11/2/2021 | Laser Acupuncture in Rheumatoid Arthritis Geriatric Patients | Laser Acupuncture in Rheumatoid Arthritis Geriatric Patients | Rheumatoid Arthritis | Combination Product: Laser, exercise, and methotrexate;Combination Product: Exercise, and methotrexate | Cairo University | NULL | Completed | 65 Years | 75 Years | All | 60 | N/A | Egypt |